Cytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.21), $0.08 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $10.11 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.